Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)

Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since. https://vimeo.com/652106617 $PBIO,...

CEO Interview: Ric Schumacher Pressure Bioscience (PBIO).

https://youtu.be/a8d1bawmMQk RELATED: Adding Pressure BioSciences (PBIO) $0.80 to Watch List Pressure BioSciences, Inc. (OTCQB:PBIO) is a global leader in providing innovative, broadly enabling, high pressure-based solutions...

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences https://youtu.be/CE7es4l1avM EDISON, N.J., (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals,...

Tsunami of Business Headed Pressure Bio’s (PBIO) Way?

We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond. As the chart...

Adding Pressure BioSciences (PBIO) $0.80 to Watch List.

Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues. Photo Ric Schumacher CEO SHORT TERM CHART LIVE QUOTE When we say "finally" meets revenues, that's...
Unicycive

Unicycive (UNCY) Shoots and Scores, up 40% Today!

We're up 126% Since December, and That Ain't Bad. Note: This isn't the end, it's just the beginning. LIVE QUOTE Adding Unicycive (UNCY) $0.75 to...

Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update

$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024 Uptick in patient recruitment for Mino-Lok® Phase 3 trial Halo-Lido Phase 2b trial nearing completion CRANFORD,...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...
pRESSURE bIOSCIENCE

Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.

CBD Supply MD, a Leading Maryland-Based CBD Retailer, to Introduce PBIO's UltraShear Processed, Best-in-Class Nanoemulsified CBD Products Across the Multi-State Mid-Atlantic Region SOUTH EASTON, MA...

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at real fireworks in the coming year....

Latest article

National Investment Bankers Conference

Companies Scheduled to Present Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...

Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.

This Week's GSA Announcement Marks Sekur’s 4th Major Milestone. GSA Approval is akin to an electrician just starting out in the business, and being told...

Halted Stocks Watch List

We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time. To...